FluoGuide A/S Sustainability Reports

FluoGuide A/S is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer tissue fluorescent. Its lead product candidate, FG001, is designed to improve surgical precision by lighting up tumors during surgery.

Sector: Professional & technical services

Country: Denmark

Exchange: Nasdaq Stockholm

LEI: 89450078OGAJQ84J9R62

FIGI: BBG00NRFC2V4

6 reports from 2020 to 2025

• FluoGuide A/S 2025 Annual Report
• FluoGuide A/S 2024 Annual Report
• FluoGuide A/S 2023 Annual Report
• FluoGuide A/S 2022 Year End Report
• FluoGuide A/S 2021 Annual Report